HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.25
+0.93%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -0.40x
- Debt / assets
- 0.11x
- Debt / EBITDA
- 0.56x
- Net debt / EBITDA
- -1.43x
Liquidity & coverage
- Current ratio
- 3.48x
- Quick ratio
- 3.45x
- Cash ratio
- 2.85x
- Interest coverage
- 17.11x
- EBITDA / interest
- 20.50x
- Working capital
- $580.3M
Cash & dividend
- FCF / debt
- 2.31x
- Cash flow / debt
- 2.31x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026